Week In Review: This Week's China Life Science Deals Total Over $2.5 Billion
June 19, 2021 at 13:37 PM EDT
Shanghai's Zai Lab announced a four-drug immunonocology deal with MacroGenics worth over $1.4 billion. Shanghai's HutchMed (formerly Hutchison Chi-Med) is planning to raise $600 million in a Hong Kong IPO.
